← Back
Data updated: Mar 29, 2026
MCPRF
Oncology
Pharma
MCPRF is a pharmaceutical company focused on Oncology.
2012
Since
4
Drugs
-
Trials
3
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
AMMONIA N 13 2026-02-13
Manufacturing (CMC)
FLUDEOXYGLUCOSE F18 2025-03-11
CHOLINE C-11 2024-09-09
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Discontinued (0)
Company Info
- First Approval
- 2012-09-12
- Latest
- 2024-09-09
- Applications
- 4